U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 115

Tests names and labsConditionsGenes, analytes, and microbesMethods

CYP2C19 Gene CYP2C19 related poor drug metabolism NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

CYP2C19

Department of Laboratory Medicine P.D. Hinduja National Hospital - MRC
India
11
  • T Targeted variant analysis

CYP2C19 (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

CYP2C19

ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories
United States
11
  • T Targeted variant analysis

CYP2C19

MVZ Dr. Eberhard & Partner Dortmund
Germany
11
  • E Sequence analysis of select exons

CYP2C19 Genotype

Mayo Clinic Laboratories Mayo Clinic
United States
121
  • T Targeted variant analysis

CYP2C19, major genotyping

Molecular Diagnostics Laboratory Seoul National University Hospital
South Korea
11
  • E Sequence analysis of select exons

CYP2C19 Genotyping

IU Genetic Testing Laboratories Indiana University School of Medicine
United States
11
  • T Targeted variant analysis

AccuType(R) CP, Clopidogrel CYP2C19 Genotype

Quest Diagnostics Nichols Institute San Juan Capistrano
United States
11
  • T Targeted variant analysis

CYP2C19 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clopidogrel, impaired responsiveness to, 609535, Autosomal recessive (Resistance to clopidogrel) (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Mephenytoin poor metabolizer, 609535, Autosomal recessive (Resistance to clopidogrel) (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Proguanil poor metabolizer, 609535, Autosomal recessive (Resistance to clopidogrel) (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Omeprazole poor metabolizer, 609535, Autosomal recessive (Resistance to clopidogrel) (CYP2C19 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

CYP2C19 drug metabolizing enzyme gene mutation

Molecular Diagnostics Children's Hospital of Wisconsin
United States
11
  • T Targeted variant analysis

Plavix Sensitivity - Genotype (CYP2C19 Genotyping)

Machaon Diagnostics
United States
11
  • T Targeted variant analysis

CYP2C19 Single Gene

Fulgent Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

AccuType(R) CP, Clopidogrel CYP2C19 Genotype (NY)

Quest Diagnostics Nichols Institute San Juan Capistrano
United States
11
  • T Targeted variant analysis

Plavix Effectiveness (CYP2C19)

Duzen Laboratories Duzen BBAGUAS
Turkey
11
  • T Targeted variant analysis

CYP2C19 genotyping

Sinochips Diagnostics
United States
151
  • T Targeted variant analysis

Results: 1 to 20 of 115

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.